(A) OS of the whole cohort. The median follow-up of the whole cohort was 6.5 months and of live patients was 21 months. (B) OS stratified by presenting SBP (mm Hg) (ie, significantly poorer OS for patients with SBP <100 mm Hg at presentation). (C) OS stratified by presenting NT-proBNP (ie, significantly poorer OS for patients with presenting NT-proBNP >8500 ng/L). (D) OS stratified by high risk factors (presenting NT-proBNP >8500 ng/L and low SBP <100 mm Hg): presence of none, 1, or 2 high risk factors identified 3 groups with median OS of 26 months vs 6 months vs 3 months, respectively (P < .0001).